DLH Holdings Corp

DLH Holdings Corp(DLHC)股票分析

$3.610

-0.020 (-0.55%)收盘时

Loading chart…
最高
3.690
开盘
3.545
成交量加权均价
3.62
成交量
3.78K
市值
152.43M
最低
3.545
成交额
13.66K
企业价值/息税折旧摊销前利润(TTM)
144.26

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems.

AI 分析 of DLH Holdings Corp (DLHC)

买入

DLH Holdings Corp is a good buy right now, trading at $3.65, which is significantly below its 52-week high of $6.88. The stock has a low forward P/E ratio of 17.45, indicating potential undervaluation, especially given the recent positive news of securing a $250 million U.S. Navy contract. However, the company has reported a concerning net income loss of $16,787,000 in Q3 2026, which poses a risk to its financial stability.

分析师评级(2)

上行空间 +177.01%
买入
2 买入
0 持有
0 卖出
当前: 3.61
最低
10.00
平均
10.00
最高
10.00

Noble Capital

2026-07-31

目标价

$7

跑赢大盘

Noble Capital

2025-05-09

目标价

$10

跑赢大盘

估值指标

DLH Holdings Corp(DLHC)当前预期市盈率为 17.45,5 年平均预期市盈率为 9.20。

预期市盈率

合理
5 年均值 P/E
9.20
当前P/E
17.45
高估
34.86
低估
-16.46

预期 EV/EBITDA

严重高估
5 年均值 EV/EBITDA
15.86
当前EV/EBITDA
144.26
高估
48.31
低估
-16.58

预期市销率

合理
5 年均值 P/S
0.41
当前P/S
0.30
高估
0.55
低估
0.28

Alphio AI 对 DLHC 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%DLHC

$5.55

情景价格

基

基准

基准 · 50%DLHC

$4.96

情景价格

悲

悲观

悲观 · 25%DLHC

$4.16

情景价格

事件时间线

2026-10-05 (ET)

09:00:00

DLH Holdings Awarded NIH Data Governance Framework Task Order

2026-09-28 (ET)

09:00:00

DLH Holdings Awarded Task Order Worth Up to $19.1M from NIH

2026-09-16 (ET)

09:00:00

DLH Holdings Awarded Task Order Worth $43.7M

2026-06-30 (ET)

16:30:00

DLH Holdings Appoints Kathryn JohnBull as New CEO

2026-06-25 (ET)

16:30:00

DLH Holdings Awarded U.S. Navy Logistics IT Contract Worth $250M

资讯

DLHC 常见问题 —— 由 Alphio AI 解答

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems. It operates in the Technology sector (SERVICES-HELP SUPPLY SERVICES industry).

DLH Holdings Corp is a good buy right now, trading at $3.65, which is significantly below its 52-week high of $6.88. The stock has a low forward P/E ratio of 17.45, indicating potential undervaluation, especially given the recent positive news of securing a $250 million U.S. Navy contract. However, the company has reported a concerning net income loss of $16,787,000 in Q3 2026, which poses a risk to its financial stability.

2 analysts cover DLHC: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 10.00.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易